Ponatinib

CAS 943319-70-8

Overview

Ponatinib works to stop cancer cells from growing to treat chronic myelogenous leukemia and acute lymphoblastic leukemia

Anant Labs manufacture and furnish high quality Ponatinib impurities for global markets. Our Ponatinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Ponatinib

CAS 943319-70-8In Stock

Technical Data

CAS943319-70-8

Mol. FormulaC₂₉H₂₇F₃N₆O

Mol. Weight532.57 g/mol

IUPAC3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide

SMILESCC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5

InChIInChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)

InChI KeyPHXJVRSECIGDHY-UHFFFAOYSA-N

Synonyms

PONATINIB943319-70-8AP24534AP 24534AP-24534ponatinibum4340891KFS3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamideCHEBI:78543DTXSID50241426